Recent advances in vaccines against viral haemorrhagic fevers

被引:6
作者
Baize, S [1 ]
Marianneau, P [1 ]
Georges-Courbot, MC [1 ]
Deubel, V [1 ]
机构
[1] Merieux Pasteur Res Ctr, Unit Biol Emerging Viral Infect, F-69365 Lyon, France
关键词
D O I
10.1097/00001432-200110000-00003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Development of vaccines against viral haemorrhagic fevers is a public health priority. Recent advances in our knowledge of pathogenesis and of the immune responses elicited by these viruses emphasize the crucial role of the immune system in the control of infection, but also its probable involvement in pathogenesis. Several vaccine candidates against viral haemorrhagic fevers have been evaluated in animals during the past year. Together, these data suggest that a vaccine approach against viral haemorrhagic fevers is feasible, should induce well-balanced immune responses with cellular and humoral components, and should avoid the potential deleterious effects that are associated with such immune responses. Curr Opin Infect Dis 14:513-518. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:513 / 518
页数:6
相关论文
共 67 条
[1]  
Avirutnan P, 1998, J IMMUNOL, V161, P6338
[2]   Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients [J].
Baize, S ;
Leroy, EM ;
Georges-Courbot, MC ;
Capron, M ;
Lansoud-Soukate, J ;
Debré, P ;
Fisher-Hoch, SP ;
McCormick, JB ;
McCormick, JB ;
Georges, AJ .
NATURE MEDICINE, 1999, 5 (04) :423-426
[3]   The Ebola virus VP35 protein functions as a type IIFN antagonist [J].
Basler, CF ;
Wang, XY ;
Mühlberger, E ;
Volchkov, V ;
Paragas, J ;
Klenk, HD ;
Garcia-Sastre, A ;
Palese, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12289-12294
[4]   Live attenuated tetravalent dengue vaccine [J].
Bhamarapravati, N ;
Sutee, Y .
VACCINE, 2000, 18 :44-47
[5]   Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs [J].
Bouloy, M ;
Janzen, C ;
Vialat, P ;
Khun, H ;
Pavlovic, J ;
Huerre, M ;
Haller, O .
JOURNAL OF VIROLOGY, 2001, 75 (03) :1371-1377
[6]   Genetic diversity among lassa virus strains [J].
Bowen, MD ;
Rollin, PE ;
Ksiazek, TG ;
Hustad, HL ;
Bausch, DG ;
Demby, AH ;
Bajani, MD ;
Peters, CJ ;
Nichol, ST .
JOURNAL OF VIROLOGY, 2000, 74 (15) :6992-7004
[7]   The role of the Type I interferon response in the resistance of mice to filovirus infection [J].
Bray, M .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :1365-1373
[8]  
CDC, 2000, MMWR, V49, P982
[9]  
Centers for Disease Control and Prevention, 2000, MMWR MORB MORTAL WKL, V49, P709
[10]  
Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P73